Vericel Corp Ownership
| VCEL Stock | USD 58.14 0.38 0.66% |
Shares in Circulation | First Issued 1996-09-30 | Previous Quarter 48.7 M | Current Value 49.1 M | Avarage Shares Outstanding 14.8 M | Quarterly Volatility 19.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Vericel |
Vericel Stock Ownership Analysis
About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 357.33. Vericel Corp Ord had not issued any dividends in recent years. The entity had 1:20 split on the 16th of October 2013. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people. For more information please call Dominick Esq at 617 588 5555 or visit https://vcel.com.Besides selling stocks to institutional investors, Vericel Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Vericel Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Vericel Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Vericel Corp Quarterly Liabilities And Stockholders Equity |
|
Vericel Corp Insider Trades History
Less than 1% of Vericel Corp Ord are currently held by insiders. Unlike Vericel Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Vericel Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Vericel Corp's insider trades
Vericel Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Vericel Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vericel Corp Ord backward and forwards among themselves. Vericel Corp's institutional investor refers to the entity that pools money to purchase Vericel Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Loomis, Sayles & Company Lp | 2024-06-30 | 1.1 M | Bnp Paribas Investment Partners Sa | 2024-06-30 | 1 M | Macquarie Group Ltd | 2024-06-30 | 1 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 910.7 K | Federated Hermes Inc | 2024-09-30 | 894.7 K | New York State Common Retirement Fund | 2024-09-30 | 862.7 K | Rtw Investments, Llc | 2024-06-30 | 801.4 K | Royal Bank Of Canada | 2024-06-30 | 762 K | William Blair Investment Management, Llc | 2024-09-30 | 756.7 K | Blackrock Inc | 2024-06-30 | 8.1 M | Brown Capital Management, Llc | 2024-09-30 | 3.8 M |
Vericel Corp Ord Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vericel Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vericel Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vericel Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vericel Corp Outstanding Bonds
Vericel Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vericel Corp Ord uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vericel bonds can be classified according to their maturity, which is the date when Vericel Corp Ord has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US92346MCG42 Corp BondUS92346MCG42 | View | |
| VeriSign 475 percent Corp BondUS92343EAL65 | View | |
| VRSN 27 15 JUN 31 Corp BondUS92343EAM49 | View | |
| VERIZON MUNICATIONS INC Corp BondUS92343VBG86 | View | |
| VeriSign 525 percent Corp BondUS92343EAH53 | View | |
| VERIZON MUNICATIONS INC Corp BondUS92343VBE39 | View | |
| US92346MBT71 Corp BondUS92346MBT71 | View | |
| US92346MBP59 Corp BondUS92346MBP59 | View |
Vericel Corp Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.08 | Revenue Per Share 4.685 | Quarterly Revenue Growth 0.27 | Return On Assets (0) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.